银酸化合物K通过激活皮细胞中的葡萄糖皮质体受体来减少与牛皮有关的炎症

相关实验视频

Updated: Jul 2, 2025

12:34

Author Spotlight: Exploring ShiDuGao's Multi-Target Approach in Anus Eczema Treatment

Published on: January 12, 2024

810

Wu Wang^1,2,3, Xiujin Xu^1,2,3, Mei Yang^1,2,3

¹Institute of Clinical Pharmacology, Anhui Medical University, Hefei, Anhui 230032, China.

Current molecular pharmacology

|February 23, 2024

概括

银酸化合物K (GCK) 通过减少炎症和角质细胞激活,有效治疗牛皮. 这种化合物作为葡萄糖皮质体受体 (GR) 激活剂,为牛皮提供了有前途的治疗方法.

科学领域:

皮肤病学皮肤病学
药理学药理学是指药理学的学科.
分子生物学分子生物学

背景情况:

牛皮是一种慢性炎症性皮肤疾病,其特征是角质细胞的过度增殖和异常分化.
金生化合物K (GCK) 是金生的代谢物,具有抗炎性质.
葡萄糖皮质体受体 (GR) 在GCK对牛皮的治疗作用中的作用尚未完全阐明.

研究的目的:

为了研究GCK对牛皮的抗炎和免疫调节作用.
阐明GCK的作用机制,重点关注其与皮细胞中葡萄糖皮质受体 (GR) 的相互作用.
评估GCK作为牛皮的潜在治疗剂.

主要方法:

一种伊米基莫德 (IMQ) 诱导的牛皮类皮肤炎小鼠模型被用于评估GCK的抗炎疗效.
分析了皮肤病理,炎症媒介 (TNF-α,IL-6,IL-8,ICAM-1),角质细胞标记物 (K1,K6,K10,K16,K17) 和GR的蛋白质和mRNA表达.
通过Western blot,免疫光和成像流细胞计学来研究NF-κB激活,p65核转位和GR转位.
细胞活力,增殖和分化在正常人体表皮角质细胞 (NHEKs) 中进行了评估,GR的作用通过小干扰RNA (siRNA) 沉默得到证实.

主要成果:

在IMQ诱导的小鼠中,GCK治疗显著降低了牛皮的严重程度,表皮厚化和超增殖.
在mRNA和蛋白质水平上,GCK减弱了关键炎症性细胞因子 (IL-6,IL-8,TNF-α,ICAM-1) 的表达.
在体外,GCK抑制了NF-κB的激活,抑制了角质细胞的增殖和异常分化,并减少了炎症介质的释放.
在NHEK中抑制GR降低了GCK的抗炎和免疫调节作用,突显了GR的关键作用.

结论:

在牛皮中,GCK通过抑制角质细胞激活来发挥其治疗作用.
GCK促进GR核转移,并抑制NF-κB的激活,从而减少炎症.
GCK作为GR激活剂起作用,是牛皮治疗的有希望的治疗候选者.

关键词:

这是一种抗炎药.人参化物化合物K 葡萄糖皮质类受体受体角质细胞 (keratinocytes) 是一种细胞.核因子是卡帕-BB.牛皮是一种病.

相关概念视频

01:12

GPCR Desensitization

6.0K

G protein-coupled receptor (GPCR) signaling plays a crucial role in cell functioning. GPCR desensitization is an equally essential process. It allows cells to respond to changing environments and regain sensitivity to new stimuli while preventing unnecessary stimulation when no longer needed. Prolonged exposure to stimuli leads to GPCR desensitization. It involves blocking the receptors from binding and activating additional G proteins. This inhibits activation of downstream effectors, thereby...

6.0K

01:24

T Cell Types and Functions

1.0K

When T cells with CD4 markers are activated, they give rise to two types of effector cells: helper T cells and regulatory T cells. Meanwhile, T cells with CD8 markers differentiate into effector cytotoxic T cells. The differentiation of CD4 T cells into helper T cell subsets, such as Th1, Th2, and Th17 cells, is dependent on the antigen type, antigen-presenting cell, and regulatory cytokines.
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...

1.0K

01:16

TGF - β Signaling Pathway

7.4K

The TGF-β signaling pathway regulates cell growth, differentiation, adhesion, motility, and development. TGF-β ligands that induce TGF-β signaling are synthesized in their latent form. Several proteases or cell surface receptors such as integrins act upon the latent form, releasing the active ligand. There are three types of mammalian TGF-βs: (TGF-β1, TGF-β2, and TGF-β3) that bind as homodimers or heterodimers to TGF-β receptors. The TGF-β receptors...

7.4K

01:20

The JAK-STAT Signaling Pathway

8.9K

Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as SH2...

8.9K

01:09

GPCRs Regulate Adenylyl Cylase Activity

5.6K

Some GPCRs transmit signals through adenylyl cyclase (AC), a transmembrane enzyme. AC helps synthesize second messenger cyclic adenosine monophosphate (cAMP). AC catalyzes cyclization reaction and converts ATP to cAMP by releasing a pyrophosphate. The pyrophosphate is further hydrolyzed to phosphate by the enzyme pyrophosphatase, which drives cAMP synthesis to completion. However, cAMP is rapidly degraded to 5′ AMP by the enzymes phosphodiesterase (PDE), preventing overstimulation of...